(LOS ANGELES) – The Terasaki Institute for Biomedical Innovation (TIBI) is pleased to announce their selection of Assistant Professors Amir Manbachi of Johns Hopkins University and Ritu Raman of the Massachusetts Institute of Technology (MIT) as the recipients of the 2024 Hisako Terasaki Young Innovator Awards. The awards will be presented at TIBI’s 2nd annual Terasaki Innovation Summit, to be held March 27-29, 2024, at the UCLA Meyer & Renee Luskin Conference Center.
(LOS ANGELES) – Vadim Jucaud, Ph.D., Assistant Professor at the Terasaki Institute for Biomedical Innovation, has been awarded a grant from the National Institutes of Health to develop a functional organ-on-a-chip to model allogeneic transplant rejection. Such a model would allow the study of allograft tolerance and may ultimately lead to reducing organ transplant rejections without needing immunosuppressive drugs.
The new year opened with a bang for the Terasaki Institute for Biomedical Innovation (TIBI), with the long-awaited completion of TIBI’s brand-new 50,000 square foot facility in Woodland Hills. TIBI scientists and staff made the big move to the new building at the end of February 2023.
In addition to the ample space and unique design features of the new building, the facility houses expansive laboratory work areas, fully arrayed with scientific equipment, as well as accommodations for meetings and seminars. This will allow for greater research capabilities and growth of the institute.
The Terasaki Institute for Biomedical Innovation (TIBI) is pleased to announce the summer junior biomedical internship program for 2024. The Institute will continue to offer summer internships for college undergraduate students interested in biomedical research or entrepreneurship.
The institute is comprised of interdisciplinary research scientists, as well as in-house innovators, who work quickly to translate their technology to real-world applications. The internship program aims to expose students to multiple fields of research to empower them to think creatively and to inspire them to explore and pursue STEM career paths.
A breakthrough gel developed for sealing and healing challenging gastrointestinal tract-to-skin connections has shown promising results in recent studies.
(LOS ANGELES) – In a major advancement in medical technology, researchers at the Terasaki Institute for Biomedical Innovation have developed an adhesive gel, offering a revolutionary treatment for gastrointestinal leaks, a condition clinically known as enterocutaneous fistulas. This development marks a significant milestone in addressing a challenging medical condition that has long plagued patients and clinicians.
More effective tumor cell death enabled via controlled, sustained delivery of chemo and immunotherapeutic drugs
(LOS ANGELES) –
Scientists from the Terasaki Institute for Biomedical Innovation (TIBI) have developed an injectable or catheter-administered hydrogel with enhanced capabilities for treating hepatocellular carcinoma (HCC), a deadly form of liver cancer. As described in their recent publication in Advanced Functional Materials, this drug-eluting hydrogel can provide sustained, pH-dependent drug co-delivery and has capabilities for promoting anti-tumor immune responses. This reduces tumor cell proliferation and growth and offers a more efficient means of enabling tumor cell death.
Scientists incorporate electrodes with beneficial features into customizable organ-on-a chip device
(LOS ANGELES) – The Terasaki Institute for Biomedical Innovation (TIBI) has developed a novel organ-on-a-chip device for measuring electrical resistance across endothelial barriers. This chip had carbon-based, screen-printed electrodes incorporated into a multi-layered, microfluidic chip fabricated by a simple and cost-effective method.
(LOS ANGELES) – September 22, 2023 - Applications are now being accepted for our 2024 Paul Terasaki Distinguished Scientist Innovation Award ($25,000 prize) and the Hisako Terasaki Young Innovator Travel Award ($5,000 prize).